FDA Approved Drugs and Resources

FDA-approved analgesics are continuously updated on the FDA's official drug database. VuRoyal Pharmaceutical specializes in supplying FDA Orange Book and Purple Book reference drugs, including hard-to-source specialty medicines for clinical trials. For the most current FDA-approved painkiller listings, we recommend consulting Drugs@FDA directly or contacting VuRoyal for reference drug sourcing support.

VuRoyal supplies Reference Listed Drugs (RLD), Reference Standards (RS), human and veterinary vaccine adjuvants including QS-21, Matrix-M, QS-7, and specialty clinical trial materials. The company also sources hard-to-find analytical testing standards and provides end-to-end logistics including cold chain transportation for temperature-sensitive pharmaceutical products.

VuRoyal is FDA-registered, a Massachusetts-approved pharmaceutical wholesaler, and holds GMP, EXCiPACT, and IPEC GMP certifications. The company operates in full compliance with USP guidelines, Title 21 CFR, the Prescription Drug Marketing Act (PDMA), the Drug Supply Chain Security Act (DSCSA), and GDP Standard Operation Protocols at federal and state levels.

QS-21 is an active ingredient in five globally approved vaccines, including those targeting shingles (Shingrix), malaria, COVID-19, and RSV. Sourced exclusively from Quillaja Saponaria Molina bark, each gram of QS-21 yields 20,000–40,000 human doses. VuRoyal is the exclusive partner of Desert King International, the world's leading QS-21 supplier, for the China market.

Yes. VuRoyal provides full end-to-end support for imported drug approval registration, import filing, and application processes in China. The company holds specialized export and operating qualifications, and its QS-21 excipient registration has successfully entered Public Notice Phase I in China as of September 2025, demonstrating deep expertise in cross-border pharmaceutical regulatory compliance.

VuRoyal serves a broad range of clients including clinical research organizations, clinical trial sponsors, vaccine developers, generic drug developers, hospitals, pharmacies, pharmaceutical manufacturers, patient service organizations, and research institutions. The company operates in the United States and China, with global supply chain capabilities to support international procurement and distribution needs.